Xbrane Biopharma

Xbrane Biopharma P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Xbrane Biopharma (XBRANE.ST) as of Nov 17, 2026 is -0.32. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -0.67 — a change of -52.36% (higher).

P/FCF

-0.32

YoY

-52.36%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Xbrane Biopharma is 2025 -0.32 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Xbrane Biopharma was 2024 -0.67 . It decreases by -52.36% higher compared to the previous year.

The Xbrane Biopharma P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
2.78 SEK
Jan 1, 2019
-0.84 SEK
Jan 1, 2020
-0.52 SEK
Jan 1, 2021
-0.42 SEK
Jan 1, 2022
-0.49 SEK
Jan 1, 2023
-0.30 SEK
Jan 1, 2024
-0.67 SEK
Jan 1, 2025
-0.32 SEK
The Xbrane Biopharma P/FCF history
YEARP/FCFYoY
-0.32-52.36%
-0.67+127.69%
-0.30-40.01%
-0.49+16.89%
-0.42-18.42%
-0.52-38.18%
-0.84-130.12%
2.78-189.11%
-3.12+28.16%
-2.43-73.73%
-9.27-78.90%
-43.92—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xbrane Biopharma Stock analysis

What does Xbrane Biopharma do? Xbrane Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xbrane Biopharma stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Xbrane Biopharma is -0.32 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Xbrane Biopharma changed from -0.67 to -0.32, representing a -52.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Xbrane Biopharma since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Xbrane Biopharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Xbrane Biopharma

All Key Metrics — Xbrane Biopharma